| Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
|---|
| 02/13/2014 | US20140045906 Neprilysin inhibitors |
| 02/13/2014 | US20140045850 Inhibitors of histone deacetylase |
| 02/13/2014 | US20140045813 Heteroaromatic compounds as btk inhibitors |
| 02/12/2014 | EP2694481A1 Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents |
| 02/12/2014 | EP2694469A2 Method for preparing formamide compounds |
| 02/12/2014 | CN103582631A Method for preparing a fluorinated organic compound |
| 02/12/2014 | CN103575827A Method for detecting monosaccharide and preparation method for derivative reagent |
| 02/12/2014 | CN103571804A 3-pyrazolyl tyrosine translation system and application thereof |
| 02/12/2014 | CN103570754A Preparation method of N-(4-(3-amino-1H-indazol-4-yl) phenyl)-N'-(2-fluoro-5-methylphenyl) urea and intermediate thereof |
| 02/12/2014 | CN103570624A Synthesis process of 3-bromo-5-nitro-1H-indazole |
| 02/12/2014 | CN103570623A Preparation method of 3-(difluoromethyl)-1-methyl-1H-pyrazol-4-carboxylic acid |
| 02/12/2014 | CN103570622A Preparation method of celecoxib |
| 02/12/2014 | CN101965329B Process for preparing 2-amino-5-cyanobenzoic acid derivatives |
| 02/11/2014 | US8648072 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 02/11/2014 | CA2685215C Compounds and methods useful for treating asthma and allergic inflammation |
| 02/11/2014 | CA2681572C Inhibitors of ion channels |
| 02/11/2014 | CA2511199C Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 02/11/2014 | CA2288330C Benzoyl amino acid derivatives useful as inhibitors of protein isoprenyl tranferases |
| 02/06/2014 | WO2014020351A1 Receptor antagonists |
| 02/06/2014 | WO2014020350A1 Par2 receptor antagonists |
| 02/06/2014 | WO2014019023A1 α7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS AND USES THEREOF-I |
| 02/06/2014 | WO2013171729A3 Aryl and heteroaryl amide compounds as ror gamma t modulator |
| 02/06/2014 | US20140039215 4-Biphenyl-substituted pyrazolidin-3,5-dione derivatives |
| 02/06/2014 | US20140039026 Polymorphs and amorphous forms of 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1h-pyrazole-3-carbonitrile |
| 02/06/2014 | US20140038975 Imidazole, Pyrazole, and Triazole Derivatives Useful As Antibacterial Agents |
| 02/06/2014 | US20140038951 Pde10 inhibitors and related compositions and methods |
| 02/06/2014 | US20140038942 RORgammaT INHIBITORS |
| 02/06/2014 | US20140038923 Pyrazole inhibitors of cox-2 and seh |
| 02/06/2014 | US20140037580 3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID bis-(MONOETHANOLAMINE) |
| 02/05/2014 | EP2691413A1 Macrocyclic compounds and methods for their production |
| 02/05/2014 | EP2691412A1 Macrocyclic compound and methods for its production |
| 02/05/2014 | CN103554026A 3-trifluoromethyl-4-formyl pyrazole compounds |
| 02/05/2014 | CN103554025A 3-pyrazole carboxylic acid amide compound and preparation method thereof as well as application of compound in preparation of medicaments as CB1 receptor inhibitors |
| 02/04/2014 | US8642780 N-carbomethoxy-N-methoxy-(2-chloromethyl)-anilines, their preparation and their use as precursors for preparing 2-(pyrazol-3′-yloxymethylene)-anilides |
| 02/04/2014 | US8642779 Compositions useful as inhibitors of protein kinases |
| 02/04/2014 | US8642637 Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof |
| 02/04/2014 | US8642626 Ethinyl-pyrazole derivative |
| 02/04/2014 | US8642625 Therapeutic agent or preventive agent for urine collection disorder |
| 02/04/2014 | US8642614 Toll-like receptor modulators and uses thereof |
| 02/04/2014 | US8642585 Indanyloxydihydrobenzofuranylacetic acids |
| 01/30/2014 | WO2014018925A1 Compositions and methods for treating microbial infections |
| 01/30/2014 | WO2014018695A1 Cannabinoid receptor antagonists/inverse agonists |
| 01/30/2014 | WO2014017643A1 Difluoromethylene compound |
| 01/30/2014 | WO2014016314A1 Fused quinonic compounds |
| 01/30/2014 | WO2013185048A3 Heterocyclic guanidine f1f0-atpase inhibitors |
| 01/30/2014 | US20140031406 Pyrazole compound |
| 01/30/2014 | US20140031404 Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers |
| 01/30/2014 | US20140031395 Positive Allosteric Modulators of the Alpha 7 Nicotinic Acetylcholine Receptor and uses Thereof |
| 01/30/2014 | US20140031370 Amide derivatives, process for preparation thereof and use thereof as insecticide |
| 01/30/2014 | US20140031331 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 01/30/2014 | US20140030243 Anthranilamides compositions |
| 01/29/2014 | EP2690095A1 Aryl gpr120 receptor agonists and uses thereof |
| 01/29/2014 | EP2690094A1 Fused quinonic compounds |
| 01/29/2014 | EP2688866A1 Trpv1 antagonists |
| 01/29/2014 | CN103547572A Process for synthesis of fipronil |
| 01/29/2014 | CN103547571A Method for producing pyrazolecarboxylic acid derivative |
| 01/29/2014 | CN103547263A Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 01/29/2014 | CN103539785A 大麻素受体调节剂 Cannabinoid receptor modulators |
| 01/29/2014 | CN103539739A Novel celecoxib crystal form B and preparation method thereof |
| 01/28/2014 | US8637678 Methods for the preparation of aryl amides |
| 01/28/2014 | US8637677 Organic dicarboxylic acids, salts and preparation method thereof |
| 01/28/2014 | US8637555 Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof |
| 01/28/2014 | CA2724065C Keratin dyeing compounds, keratin dyeing compositions containing said compounds, and use thereof |
| 01/28/2014 | CA2535265C Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 01/23/2014 | WO2014012975A1 Process for the preparation of 5-fluoro-1h-pyrazoles |
| 01/23/2014 | WO2014012935A1 Substituted aminoindane- and aminotetralincarboxylic acids and use thereof |
| 01/23/2014 | US20140024835 Dual-acting antihypertensive agents |
| 01/23/2014 | US20140024657 Small molecule inhibitors of necroptosis |
| 01/23/2014 | US20140024650 Sulfonamide derivative and use thereof |
| 01/22/2014 | EP2687515A1 Method for producing pyrazolecarboxylic acid derivative |
| 01/22/2014 | EP2687514A1 Process for the preparation of derivatives of 1-substituted-3-fluoroalkyl-pyrazole-4-carboxylic acid in the presence of ammonium salt |
| 01/22/2014 | EP2687513A1 Drugs for inhibiting aggregation of proteins invoved in diseases linked to protein aggregation and/or neurodegenerative diseases |
| 01/22/2014 | EP2686303A1 N-(3-carbamoylphenyl)-1h-pyrazole-5-carboxamide derivatives and the use thereof for controlling animal pests |
| 01/22/2014 | CN103534239A Substituted indazole derivatives active as kinase inhibitors |
| 01/22/2014 | CN103524421A Novel naphthoyl urea derivate and medical application thereof |
| 01/22/2014 | CN103524420A Keratin dyeing compounds, keratin dyeing compositions containing said compounds, and use thereof |
| 01/22/2014 | CN103524419A Group of 3-trifluoromethyl pyrazole compounds |
| 01/22/2014 | CN103524418A 3-methyl pyrazol compounds |
| 01/22/2014 | CN103524417A 3-methyl-4-formyl pyrazol compounds |
| 01/22/2014 | CN103524416A Novel crystal form A of celecoxib and preparation method thereof |
| 01/22/2014 | CN101772487B Thyroid compounds |
| 01/21/2014 | US8633237 Indane derivatives |
| 01/21/2014 | US8633182 Indanyloxyphenylcyclopropanecarboxylic acids |
| 01/16/2014 | WO2014012074A2 No-releasing nonoate (nitrogen-bound) sulfonamide-linked-coxib anti-cancer agents |
| 01/16/2014 | WO2014012000A2 No-releasing guanidine-coxib anti-cancer agents |
| 01/16/2014 | US20140018544 No-releasing nonoate(nitrogen-bound)sulfonamide-linked-coxib anti-cancer agents |
| 01/16/2014 | US20140018403 No-releasing guanidine-coxib anti-cancer agents |
| 01/16/2014 | US20140018326 Sulfonamides as hib protease inhibitors |
| 01/15/2014 | EP2684873A1 Drugs for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases |
| 01/15/2014 | EP2683693A1 Rorgammat inhibitors |
| 01/15/2014 | EP2683692A1 Process for preparing substituted n-phenylhydroxylamines |
| 01/15/2014 | EP2683682A1 Process for the synthesis of aminobiphenylene |
| 01/15/2014 | CN103517893A Process for the synthesis of aminobiphenylene |
| 01/15/2014 | CN103508960A Benzoheterocyclic derivatives |
| 01/15/2014 | CN103508959A Synthesis method of 1-methyl-3-ethyl-5-pyrazolyl ethyl carboxylate |
| 01/15/2014 | CN103508958A Novel celecoxib crystal form C and preparation method thereof |
| 01/15/2014 | CN103508957A Hydroxyethyl pyrazole compound or aminoethyl pyrazole compound, preparation method and use thereof |
| 01/14/2014 | US8629288 Method for the regioselective synthesis of 1-alky1-3-haloalkyl-pyrazole-4-carboxylic acid derivatives |
| 01/14/2014 | US8629287 Process for the sulfinylation of a pyrazole derivative |
| 01/14/2014 | US8629286 Pyrazole derivatives |